Chul Hyoung Lyoo
Overview
Explore the profile of Chul Hyoung Lyoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
3002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Kim H, Ahn S, Park M, Yoo H, Lyoo C
NPJ Parkinsons Dis
. 2025 Feb;
11(1):33.
PMID: 39979309
To elucidate the role of basal forebrain (BF) in non-motor symptoms of Parkinson's disease (PD), we investigated the association of sleep quality and cognition with BF volume and functional connectivity....
2.
Song Y, Lee J, Kim H, Lee J, Ryu Y, Yoo H, et al.
J Nucl Med
. 2025 Jan;
66(2):286-292.
PMID: 39746754
Parkinson disease (PD) is a multisystem disorder marked by progressive dopaminergic neuronal degeneration in the substantia nigra, as well as nondopaminergic systems. Our aim was to investigate longitudinal changes in...
3.
Yoo H, Kim H, Na H, Kang S, Park M, Ahn S, et al.
Neurology
. 2024 Nov;
103(12):e210105.
PMID: 39602663
Background And Objectives: Parkinson disease (PD) shows degeneration of dopaminergic neurons in the substantia nigra and characteristic changes in brain metabolism. However, how they correlated and affect motor and cognitive...
4.
Oh E, Cheon S, Cho J, Sung Y, Kim J, Shin H, et al.
J Neural Transm (Vienna)
. 2024 Nov;
132(3):431-441.
PMID: 39540934
This multicentre, prospective, single-arm study evaluated safinamide as add-on therapy to levodopa in Korean patients with Parkinson's disease (PD) with motor fluctuations with ≥ 1.5 h of "off" time daily,...
5.
Cho J, Lee J, Kim H, Kim J, Park K, Choi S, et al.
J Mov Disord
. 2024 Oct;
18(1):35-44.
PMID: 39428104
Objective: We conducted this study to assess the efficacy and safety of taltirelin hydrate (TH) in patients with ataxia due to spinocerebellar degeneration (SCD). Methods: Patients were randomly assigned to...
6.
Yoo S, Ryu D, Oh Y, Ha S, Lyoo C, Kim J
J Neurol
. 2024 Jul;
271(9):6102-6113.
PMID: 39043904
Background: Hyposmia in Parkinson's disease (PD) had been studied before but had not been detailed by its temporal progression. This study observed how each olfactory subtype evolved in terms of...
7.
Park M, Kim H, Baik K, Na H, Lee Y, Yoon S, et al.
Eur J Neurol
. 2024 Jul;
31(10):e16364.
PMID: 39034046
Background And Purpose: The co-occurrence of amyloid-β pathology in Parkinson's disease (PD) is common; however, the role of amyloid-β deposition in motor prognosis remains elusive. This study aimed to investigate...
8.
Oh Y, Kim J, Lyoo C, Park G, Kim H
Neurology
. 2024 Jun;
103(2):e209498.
PMID: 38885485
Background And Objectives: Cognitive impairment is a frequent nonmotor symptom in patients with Parkinson disease (PD), and early cognitive decline is often attributed to dopaminergic system dysfunction. We aimed to...
9.
Groot C, Smith R, Collij L, Mastenbroek S, Stomrud E, Binette A, et al.
JAMA Neurol
. 2024 Jun;
81(8):845-856.
PMID: 38857029
Importance: An accurate prognosis is especially pertinent in mild cognitive impairment (MCI), when individuals experience considerable uncertainty about future progression. Objective: To evaluate the prognostic value of tau positron emission...
10.
Yoo H, Kim H, Lee H, Yoon S, Na H, Kang S, et al.
J Neurol
. 2024 Jun;
271(8):5213-5222.
PMID: 38839638
Background: Parkinson's disease (PD) manifests as a wide variety of clinical phenotypes and its progression varies greatly. However, the factors associated with different disease progression remain largely unknown. Methods: In...